Targeting CXCR4-expressing Cancer Cells with Avidin-poly (lactic-co-glycolic acid) Nanoparticle Surface Modified with Biotinylated DV1 Peptide

BACKGROUND: Chemokine receptor CXCR4 is frequently present in cells of various cancers. Hence, targeted therapy using CXCR4 ligands, such as DV1 peptide, on drug-loaded nanoparticles, has the potential to enhance the efficiency of cancer treatment. AIM: The present study created a CXCR4-targeting dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Shiba, Mudassir, Madeeha, Vijayalekshmi, B., Chattopadhyay, Parthaprasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443452/
https://www.ncbi.nlm.nih.gov/pubmed/37614837
http://dx.doi.org/10.4103/ijabmr.ijabmr_58_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443452/
https://www.ncbi.nlm.nih.gov/pubmed/37614837
http://dx.doi.org/10.4103/ijabmr.ijabmr_58_23

Ejemplares similares